Necrotizing fasciitis pathophysiology: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(99 intermediate revisions by 4 users not shown)
Line 4: Line 4:


==Overview==
==Overview==
The pathophysiology of necrotizing fasciitis is common to all types, but the speed of development and associated clinical features differs depending on the causative organisms. Following transmission, the bacteria uses the entry site to invade the [[Fascia|fascial planes]] which causes the wide spread necrosis of [[Fascia|superficial fascia]], [[Fascia|deep fascia]], [[subcutaneous fat]], [[nerves]], [[arteries]], and [[veins]]. Necrotizing fasciitis can be a serious complication of [[omphalitis]] in the [[neonate]]. The pathogenesis of necrotizing fasciitis is the result of bacterial and host factors. The exact pathogenesis of type 1 necrotizing fasciitis is not fully understood but [[polymicrobial]] species work [[Synergistic|synergistically]] to enhance the spread of infection. [[Streptococcus|Group A streptococcus]] is the most common causative agent of type 2 necrotizing fasciitis. Bacterial [[virulence factors]], [[exotoxins]], [[superantigens]] and [[host]] [[immune system]] plays a major role in the pathogenesis of type II necrotizing fasciitis. Recurrent necrotizing fasciitis is caused by [[MRSA]]. On gross pathology, the characteristic findings of necrotizing fasciitis include [[Emphysema|subcutaneous emphysema]], skin sloughing, bulae and [[necrosis]]. [[Inflammation|Inflammatory changes]] are seen on microscopic histopathology.<ref name="pmid25593960">{{cite journal| author=Misiakos EP, Bagias G, Patapis P, Sotiropoulos D, Kanavidis P, Machairas A| title=Current concepts in the management of necrotizing fasciitis. | journal=Front Surg | year= 2014 | volume= 1 | issue=  | pages= 36 | pmid=25593960 | doi=10.3389/fsurg.2014.00036 | pmc=4286984 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25593960  }} </ref>


==Pathophysiology==
==Pathophysiology==
The pathophysiology of necrotizing fasciitis is common to all types of NF but the speed of development and associated clinical features differs depending on the causative organisms.
The pathophysiology of necrotizing fasciitis is common to all types of necrotizing fasciitis, but the speed of development and associated clinical features differs depending on the causative organisms.<ref name="pmid25593960">{{cite journal| author=Misiakos EP, Bagias G, Patapis P, Sotiropoulos D, Kanavidis P, Machairas A| title=Current concepts in the management of necrotizing fasciitis. | journal=Front Surg | year= 2014 | volume= 1 | issue=  | pages= 36 | pmid=25593960 | doi=10.3389/fsurg.2014.00036 | pmc=4286984 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25593960  }} </ref>
*The transmission of pathogens occurs through the following routes
*The transmission of pathogens occurs through the following routes:<ref name="pmid18476182">{{cite journal| author=Lynch CM, Pinelli DM, Cruse CW, Spellacy WN, Sinnott JT, Shashy RG| title=Maternal death from postpartum necrotizing fasciitis arising in an episiotomy: a case report. | journal=Infect Dis Obstet Gynecol | year= 1997 | volume= 5 | issue= 5 | pages= 341-4 | pmid=18476182 | doi=10.1155/S1064744997000598 | pmc=2364577 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18476182  }} </ref><ref name="pmid20542593">{{cite journal| author=Morgan MS| title=Diagnosis and management of necrotising fasciitis: a multiparametric approach. | journal=J Hosp Infect | year= 2010 | volume= 75 | issue= 4 | pages= 249-57 | pmid=20542593 | doi=10.1016/j.jhin.2010.01.028 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20542593  }} </ref>
:*External trauma
:*External trauma (e.g., [[laceration]], [[abrasion]], [[burn]], insect bite)
:*Direct spread from a perforated viscus (particularly colon, rectum, or anus)
:*Direct spread from a perforated [[viscus]] (particularly [[colon]], [[rectum]], or [[anus]]) or another surgical procedure (e.g., [[vasectomy]], [[hemorrhoidectomy]])
:*Urogenital organ  
:*[[Urogenital|Urogenital organ]]
*Following transmission, the bacteria uses the entry site to invade the fascial planes which causes the wide spread necrosis of superficial fascia, subcutaneous fat, nerves, arteries and veins.
:*[[Perirectal abscess]]
:*[[Decubitus ulcer]]
*Following transmission, the bacteria uses the entry site to invade the [[Fascia|fascial planes]] which causes the wide spread necrosis of [[Fascia|superficial fascia]], [[Fascia|deep fascia]], [[subcutaneous fat]], [[nerves]], [[arteries]], and [[veins]].
*Superficial skin and deeper muscles are typically spared.
*In late stages, lesions develop [[liquefactive necrosis]] at all tissue levels.
 
'''Necrotizing fasciitis in neonate'''
*Necrotizing fasciitis can be a serious complication of [[omphalitis]] in the [[neonate]].
*The omphalitis may progress resulting in purplish discoloration and [[Necrosis|periumbilical necrosis]].
*The necrosis may extend to the [[flanks]] and even onto the chest wall.
 
===Pathogenesis===
===Pathogenesis===
The pathogenesis of necrotizing fasciitis is the result of bacterial and host factors.
The pathogenesis of necrotizing fasciitis is the result of bacterial and host factors.<ref name="pmid6727947">{{cite journal| author=Stamenkovic I, Lew PD| title=Early recognition of potentially fatal necrotizing fasciitis. The use of frozen-section biopsy. | journal=N Engl J Med | year= 1984 | volume= 310 | issue= 26 | pages= 1689-93 | pmid=6727947 | doi=10.1056/NEJM198406283102601 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6727947  }} </ref><ref name="pmid8916882">{{cite journal| author=Elliott DC, Kufera JA, Myers RA| title=Necrotizing soft tissue infections. Risk factors for mortality and strategies for management. | journal=Ann Surg | year= 1996 | volume= 224 | issue= 5 | pages= 672-83 | pmid=8916882 | doi= | pmc=1235444 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8916882  }} </ref>
 
'''Bacterial Factors'''


'''Type 1 NF'''
'''Type 1 NF'''
*The exact pathogenesis of type 1 necrotizing fasciitis is not fully understood.
*The exact pathogenesis of type 1 necrotizing fasciitis is not fully understood.
*It is thought that type 1 NF is caused by polymicrobial species that work together to enhance the spread of infection (Synergistic).
*It is thought that type 1 NF is caused by polymicrobial species that work [[Synergistic|synergistically]] to enhance the spread of infection.
*Synergistic NF is comparatively slow process evolving over days.
*It usually develops in the area where [[gut flora]] breaches the [[mucosa]], entering the tissue planes.
'''Type 2 NF'''  
'''Type 2 NF'''  
*[[Streptococcus|Group A streptococcus]] is the most common causative agent of type 2 NF.
*[[Streptococcus|Group A streptococcus]] is the most common causative agent of type 2 NF.<ref name="pmid10925760">{{cite journal| author=Leitch HA, Palepu A, Fernandes CM| title=Necrotizing fasciitis secondary to group A streptococcus. Morbidity and mortality still high. | journal=Can Fam Physician | year= 2000 | volume= 46 | issue=  | pages= 1460-6 | pmid=10925760 | doi= | pmc=2144855 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10925760  }} </ref><ref name="pmid23753218">{{cite journal| author=Shiroff AM, Herlitz GN, Gracias VH| title=Necrotizing soft tissue infections. | journal=J Intensive Care Med | year= 2014 | volume= 29 | issue= 3 | pages= 138-44 | pmid=23753218 | doi=10.1177/0885066612463680 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23753218  }} </ref>
*The pathogenesis of type 2 NF is the result of virulence factors of [[streptococcus]] which includes
*Type 2 NF is initially insidious in onset but progress more rapidly.<ref name="pmid7748037">{{cite journal| author=McHenry CR, Piotrowski JJ, Petrinic D, Malangoni MA| title=Determinants of mortality for necrotizing soft-tissue infections. | journal=Ann Surg | year= 1995 | volume= 221 | issue= 5 | pages= 558-63; discussion 563-5 | pmid=7748037 | doi= | pmc=1234638 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7748037  }} </ref>
:*Adherence of bacteria to host tissue
*The disease may appear spontaneously with no obvious focus. Hematogenous infection from many foci such as [[skin]], [[throat]], [[Vaginitis|ascending vaginitis]], [[Peritonitis|primary peritonitis]] reaches the fascial layer or seeds [[vimentin]] exposed by muscle damage.
::*Protein F (fibronectin binding protein)
*Direct inoculation of [[Streptococcus|GAS]] through wounds or associated surgery is less common.
::*[[Lipoteichoic acid]]  
*The pathogenesis of type 2 NF is the result of the following process:
::*[[M protein]] that mediate attachment of pathogen to host cells.
:*Inhibition of [[phagocytosis]] of bacteria by [[Capsule|hyaluronic acid capsule]] and [[M protein]]
:*Inhibition of phagocytosis
:*Adherence of bacteria to host cell through adherence factors such as [[M protein]], protein F and [[lipoteichoic acid]]<ref name="pmid7934492">{{cite journal| author=Chelsom J, Halstensen A, Haga T, Høiby EA| title=Necrotising fasciitis due to group A streptococci in western Norway: incidence and clinical features. | journal=Lancet | year= 1994 | volume= 344 | issue= 8930 | pages= 1111-5 | pmid=7934492 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7934492  }} </ref>
::*[[Hyaluronic acid|Hyaluronic acid capsule]]
:*Release of [[exotoxins]] (streptococcal pyogenic exotoxins and [[superantigen]]) into blood produce massive proliferation of [[T cells]] and cascading release of [[cytokines]] activating inflammatory process
::*[[M protein]]
:*Activation of inflammatory process which begins to kill [[bacteria]]
:*[[Exotoxins|Extracellular exotoxins]]
:*The [[streptococci]] release massive amounts of [[enzymes]], [[Hemolysin|hemolysins]], [[DNAase]], [[proteases]] and [[collagenases]] which destroy the normal skin and surrounding tissue with progressive [[Necrosis|coagulative necrosis]]  
::*[[Streptokinase]]
:*The inflamed cells release more [[cytokines]] that stimulate more inflammatory cells
::*Streptolysin O and S
:*The massive release of [[cytokines]] result in [[systemic inflammatory response syndrome]] resulting in [[shock]], organ failure, depression of myocardial function and immune suppression
::*Streptodornase (DNase B)
:*Stimulation of [[T-cells]] by [[superantigen]] causes activation of [[Complement system|complement pathway]], the [[bradykinin]]-[[kallikrein]] system, and the [[coagulation cascade]], worsening small vessel [[thrombosis]] and tissue ischemia. [[Ischemia|Tissue ischemia]] impedes oxidative destruction of [[bacteria]] by [[polymorphonuclear cells]] and prevents adequate delivery of antibiotics.
::*[[Hyaluronidase]]
:*The blood flow to local tissue is compromised due to thrombosis of large number of dermal capillaries by the local [[Coagulation|hypercoaguable state]], [[platelet]]-[[neutrophil]] plugging of vessels and increased [[interstitial|interstitial pressure]]
::*Streptococcal pyrogenic exotoxins (Spe)
*Nerves supplying the necrotizing areas of skin die, the central areas become [[anaesthetic]] and peripheral areas remain tender
:*[[Superantigen]]
*In later stages, infection from deeper layers ascends, producing [[edema]] of epidermal and dermal layers ([[peau d'orange]]) and a woody firmness of the tissues
*These virulence factors are variably used by bacteria throughout each stage of infection (initiation, local replication and dissemination), which requires the highly coordinated regulation of virulence gene expression.
*The fascial and nerve destruction results in [[sensory]] and motor deficits, which causes progression of hemorrhagic bulae to cutaneous gangrene
 
'''Recurrent necrotizing fasciitis'''
 
Recurrent NF is seen in following conditions:<ref name="pmid15814880">{{cite journal| author=Miller LG, Perdreau-Remington F, Rieg G, Mehdi S, Perlroth J, Bayer AS et al.| title=Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. | journal=N Engl J Med | year= 2005 | volume= 352 | issue= 14 | pages= 1445-53 | pmid=15814880 | doi=10.1056/NEJMoa042683 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15814880  }} </ref>
*Methicillin resistant staphylococcus aureus ([[MRSA]])
*[[Complement deficiency|Complement C4 deficiency]]


'''Host factors'''
===Gross pathology===
On gross pathology the characteristic findings of necrotizing fasciitis include:<ref name=NF>Librae pathology(2015) https://librepathology.org/wiki/Necrotizing_fasciitis Accessed on September 2,2016 </ref>
*[[Emphysema|Subcutaneous emphysema]]
*[[Edema]]
*[[Erythema]]
*Bulae
*Skin sloughing
*Dull grey discoloration
<gallery>
<gallery>
Image:Virulence_factors.PNG|200px
 
Image:800px-Necrotizing_fasciitis_left_leg.JPEG|By Nephron - Own work, CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=19107063
 
</gallery>
</gallery>


===Microscopic Pathology===
On microscopic histopathological analysis, the characteristic findings of necrotizing fasciitis are<ref name=NF>Librae pathology(2015) https://librepathology.org/wiki/Necrotizing_fasciitis Accessed on September 2,2016 </ref>
*Early stages
:*[[Vasculitis|Obliterative vasculitis]] with microangiopathic thrombosis
:*Acute inflammation of subcutaneous tissue
:*Superficial hyaline necrosis along with [[edema]] and [[inflammation]] of the dermis and subcutaneous fat
:*Dense [[neutrophil]]-predominant inflammatory infiltrate
*Late stages
:*Noninflammatory [[Coagulation|intravascular coagulation]] and [[hemorrhage]]
:*[[Myonecrosis]]
<gallery>


Image:80px-Necrotizing_fasciitis_-_high_mag.jpg|By Piotr Smuszkiewicz, Iwona Trojanowska and Hanna Tomczak - Late diagnosed necrotizing fasciitis as a cause of multiorgan dysfunction syndrome: A case report. Cases Journal 2008, 1:125. doi:10.1186/1757-1626-1-125, CC BY 2.0, https://commons.wikimedia.org/w/index.php?curid=5639655


“Flesh-eating bacteria” is a misnomer, as the bacteria do not actually eat the tissue. They cause the destruction of skin and muscle by releasing [[toxin]]s (virulence factors). These include streptococcal pyogenic exotoxins and [[Streptococcus pyogenes|other virulence factors]]. ''S. pyogenes'' produces an exotoxin known as a [[superantigen]]. This toxin is capable of activating [[T-cell]]s non-specifically. This causes the over-production of [[cytokines]] that over-stimulate [[macrophage]]s. The macrophages cause the actual tissue damage by releasing oxygen [[free radicals]] that are normally intended to destroy bacteria but are capable of damaging nearly any macromolecule they contact in the body.
Image:120px-Necrotizing_fasciitis_-_intermed_mag.jpg|By Piotr Smuszkiewicz, Iwona Trojanowska and Hanna Tomczak - Late diagnosed necrotizing fasciitis as a cause of multiorgan dysfunction syndrome: A case report. Cases Journal 2008, 1:125. doi:10.1186/1757-1626-1-125, CC BY 2.0, https://commons.wikimedia.org/w/index.php?curid=5639655
 
</gallery>


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}


[[Category:Emergency mdicine]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Dermatology]]
[[Category:Up-To-Date]]
[[Category:Infectious disease]]
[[Category:Infectious disease]]
[[Category:Rheumatology]]
[[Category:Surgery]]
[[Category:Orthopedics]]

Latest revision as of 22:56, 29 July 2020

Necrotizing fasciitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Necrotizing fasciitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Biopsy

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Necrotizing fasciitis pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Necrotizing fasciitis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Necrotizing fasciitis pathophysiology

CDC on Necrotizing fasciitis pathophysiology

Necrotizing fasciitis pathophysiology in the news

Blogs on Necrotizing fasciitis pathophysiology

Directions to Hospitals Treating Necrotizing fasciitis

Risk calculators and risk factors for Necrotizing fasciitis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Yamuna Kondapally, M.B.B.S[2]

Overview

The pathophysiology of necrotizing fasciitis is common to all types, but the speed of development and associated clinical features differs depending on the causative organisms. Following transmission, the bacteria uses the entry site to invade the fascial planes which causes the wide spread necrosis of superficial fascia, deep fascia, subcutaneous fat, nerves, arteries, and veins. Necrotizing fasciitis can be a serious complication of omphalitis in the neonate. The pathogenesis of necrotizing fasciitis is the result of bacterial and host factors. The exact pathogenesis of type 1 necrotizing fasciitis is not fully understood but polymicrobial species work synergistically to enhance the spread of infection. Group A streptococcus is the most common causative agent of type 2 necrotizing fasciitis. Bacterial virulence factors, exotoxins, superantigens and host immune system plays a major role in the pathogenesis of type II necrotizing fasciitis. Recurrent necrotizing fasciitis is caused by MRSA. On gross pathology, the characteristic findings of necrotizing fasciitis include subcutaneous emphysema, skin sloughing, bulae and necrosis. Inflammatory changes are seen on microscopic histopathology.[1]

Pathophysiology

The pathophysiology of necrotizing fasciitis is common to all types of necrotizing fasciitis, but the speed of development and associated clinical features differs depending on the causative organisms.[1]

  • The transmission of pathogens occurs through the following routes:[2][3]

Necrotizing fasciitis in neonate

  • Necrotizing fasciitis can be a serious complication of omphalitis in the neonate.
  • The omphalitis may progress resulting in purplish discoloration and periumbilical necrosis.
  • The necrosis may extend to the flanks and even onto the chest wall.

Pathogenesis

The pathogenesis of necrotizing fasciitis is the result of bacterial and host factors.[4][5]

Type 1 NF

  • The exact pathogenesis of type 1 necrotizing fasciitis is not fully understood.
  • It is thought that type 1 NF is caused by polymicrobial species that work synergistically to enhance the spread of infection.
  • Synergistic NF is comparatively slow process evolving over days.
  • It usually develops in the area where gut flora breaches the mucosa, entering the tissue planes.

Type 2 NF

  • Group A streptococcus is the most common causative agent of type 2 NF.[6][7]
  • Type 2 NF is initially insidious in onset but progress more rapidly.[8]
  • The disease may appear spontaneously with no obvious focus. Hematogenous infection from many foci such as skin, throat, ascending vaginitis, primary peritonitis reaches the fascial layer or seeds vimentin exposed by muscle damage.
  • Direct inoculation of GAS through wounds or associated surgery is less common.
  • The pathogenesis of type 2 NF is the result of the following process:
  • Nerves supplying the necrotizing areas of skin die, the central areas become anaesthetic and peripheral areas remain tender
  • In later stages, infection from deeper layers ascends, producing edema of epidermal and dermal layers (peau d'orange) and a woody firmness of the tissues
  • The fascial and nerve destruction results in sensory and motor deficits, which causes progression of hemorrhagic bulae to cutaneous gangrene

Recurrent necrotizing fasciitis

Recurrent NF is seen in following conditions:[10]

Gross pathology

On gross pathology the characteristic findings of necrotizing fasciitis include:[11]

Microscopic Pathology

On microscopic histopathological analysis, the characteristic findings of necrotizing fasciitis are[11]

  • Early stages
  • Late stages

References

  1. 1.0 1.1 Misiakos EP, Bagias G, Patapis P, Sotiropoulos D, Kanavidis P, Machairas A (2014). "Current concepts in the management of necrotizing fasciitis". Front Surg. 1: 36. doi:10.3389/fsurg.2014.00036. PMC 4286984. PMID 25593960.
  2. Lynch CM, Pinelli DM, Cruse CW, Spellacy WN, Sinnott JT, Shashy RG (1997). "Maternal death from postpartum necrotizing fasciitis arising in an episiotomy: a case report". Infect Dis Obstet Gynecol. 5 (5): 341–4. doi:10.1155/S1064744997000598. PMC 2364577. PMID 18476182.
  3. Morgan MS (2010). "Diagnosis and management of necrotising fasciitis: a multiparametric approach". J Hosp Infect. 75 (4): 249–57. doi:10.1016/j.jhin.2010.01.028. PMID 20542593.
  4. Stamenkovic I, Lew PD (1984). "Early recognition of potentially fatal necrotizing fasciitis. The use of frozen-section biopsy". N Engl J Med. 310 (26): 1689–93. doi:10.1056/NEJM198406283102601. PMID 6727947.
  5. Elliott DC, Kufera JA, Myers RA (1996). "Necrotizing soft tissue infections. Risk factors for mortality and strategies for management". Ann Surg. 224 (5): 672–83. PMC 1235444. PMID 8916882.
  6. Leitch HA, Palepu A, Fernandes CM (2000). "Necrotizing fasciitis secondary to group A streptococcus. Morbidity and mortality still high". Can Fam Physician. 46: 1460–6. PMC 2144855. PMID 10925760.
  7. Shiroff AM, Herlitz GN, Gracias VH (2014). "Necrotizing soft tissue infections". J Intensive Care Med. 29 (3): 138–44. doi:10.1177/0885066612463680. PMID 23753218.
  8. McHenry CR, Piotrowski JJ, Petrinic D, Malangoni MA (1995). "Determinants of mortality for necrotizing soft-tissue infections". Ann Surg. 221 (5): 558–63, discussion 563-5. PMC 1234638. PMID 7748037.
  9. Chelsom J, Halstensen A, Haga T, Høiby EA (1994). "Necrotising fasciitis due to group A streptococci in western Norway: incidence and clinical features". Lancet. 344 (8930): 1111–5. PMID 7934492.
  10. Miller LG, Perdreau-Remington F, Rieg G, Mehdi S, Perlroth J, Bayer AS; et al. (2005). "Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles". N Engl J Med. 352 (14): 1445–53. doi:10.1056/NEJMoa042683. PMID 15814880.
  11. 11.0 11.1 Librae pathology(2015) https://librepathology.org/wiki/Necrotizing_fasciitis Accessed on September 2,2016